Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients

Prophylactic donor lymphocyte infusion (DLI) starting at 6 months after T cell-depleted allogeneic stem cell transplantation (TCD-alloSCT) can introduce a graft-versus-leukemia (GvL) effects with low risk of severe graft-versus-host-disease (GvHD). We established a policy to apply low-dose early DLI...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zouwen, Boris, Koster, E. A. S., von dem Borne, P. A., Oosten, L. E. M., Roza-Scholten, M. W. I., Snijders, T. J. F., van Lammeren, D., van Balen, P., Marijt, W. A. F., Veelken, H., Falkenburg, J. H. F., de Wreede, L. C., Halkes, C. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102042/
https://www.ncbi.nlm.nih.gov/pubmed/36881136
http://dx.doi.org/10.1007/s00277-023-05145-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102042/
https://www.ncbi.nlm.nih.gov/pubmed/36881136
http://dx.doi.org/10.1007/s00277-023-05145-1

Ejemplares similares